Biodefence Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Biodefense Market to 2027 - Global Analysis and Forecasts By Product (Anthrax, Small Pox, Botulism, Radiation/Nuclear, Others.); Devices (Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents)

Report Code: TIPRE00005377 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Biodefense is referred to the measures taken to restore biosecurity of a group of organism who are, or may be, subject to biological threats or infectious diseases. It is an effective public health care system with strong disease surveillance and rapid actions designed to counter biological threats, to limit the spread of disease and provide surge medical care.

MARKET DYNAMICS
The Biodefense market is anticipated to grow in the forecast, owing to the factors such as increasing government initiatives, increasing adoption of technologies such as gene chips for pathogen detection in forensic division, nanotechnology, growing prevalence of infectious diseases, such as influenza, congenital Zika virus etc., and nuclear crisis in several regions. Nevertheless, low r&d funding for manufacturing vaccines against bioterrorism attacks in expected to restrict the growth of the market during the forecast period.

MARKET SCOPE
The "Global Biodefense Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Biodefense market with detailed market segmentation by product, devices and geography. The global Biodefense market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biodefense market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Biodefense market is segmented on the basis of product and devices. Based on product the market is segmented into anthrax, small pox, botulism, radiation/nuclear, and others. Based on devices the market is segmented into samplers, detectors/triggering devices, identifiers, assays and reagents.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biodefense market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Biodefense market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Biodefense market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Biodefense market in these regions.

MARKET PLAYERS
The reports cover key developments in the Biodefense market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Biodefense market are anticipated to lucrative growth opportunities in the future with the rising demand for Biodefense market in the global market. Below mentioned is the list of few companies engaged in the Biodefense market.

The report also includes the profiles of Biodefense market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Alnylam Pharmaceuticals, Inc.
  •  Bavarian Nordic
  •  Achaogen, Inc
  •  General Dynamics Information Technology, Inc. (Dynport Vaccine Company LLC)
  •  Ichor Medical Systems.
  •  Cleveland Bio Labs
  •  Emergent Biosolutions Inc.
  •  Dynavax Technologies Corporation
  •  Xoma Corporation
  •  Elusys Therapeutics, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biodefense Market - By Product
1.3.2 Biodefense Market - By Devices
1.3.3 Biodefense Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. BIODEFENSE MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BIODEFENSE MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BIODEFENSE MARKET - GLOBAL MARKET ANALYSIS

6.1. BIODEFENSE - GLOBAL MARKET OVERVIEW
6.2. BIODEFENSE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIODEFENSE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ANTHRAX
7.3.1. Overview
7.3.2. Anthrax Market Forecast and Analysis
7.4. SMALL POX
7.4.1. Overview
7.4.2. Small Pox Market Forecast and Analysis
7.5. BOTULISM
7.5.1. Overview
7.5.2. Botulism Market Forecast and Analysis
7.6. RADIATION/NUCLEAR
7.6.1. Overview
7.6.2. Radiation/Nuclear Market Forecast and Analysis
7.7. OTHERS.
7.7.1. Overview
7.7.2. Others. Market Forecast and Analysis

8. BIODEFENSE MARKET - REVENUE AND FORECASTS TO 2027 - DEVICES

8.1. OVERVIEW
8.2. DEVICES MARKET FORECASTS AND ANALYSIS
8.3. SAMPLERS
8.3.1. Overview
8.3.2. Samplers Market Forecast and Analysis
8.4. DETECTORS/TRIGGERING DEVICES
8.4.1. Overview
8.4.2. Detectors/Triggering Devices Market Forecast and Analysis
8.5. IDENTIFIERS
8.5.1. Overview
8.5.2. Identifiers Market Forecast and Analysis
8.6. ASSAYS AND REAGENTS.
8.6.1. Overview
8.6.2. Assays and Reagents. Market Forecast and Analysis

9. BIODEFENSE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Biodefense Market Overview
9.1.2 North America Biodefense Market Forecasts and Analysis
9.1.3 North America Biodefense Market Forecasts and Analysis - By Product
9.1.4 North America Biodefense Market Forecasts and Analysis - By Devices
9.1.5 North America Biodefense Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biodefense Market
9.1.5.1.1 United States Biodefense Market by Product
9.1.5.1.2 United States Biodefense Market by Devices
9.1.5.2 Canada Biodefense Market
9.1.5.2.1 Canada Biodefense Market by Product
9.1.5.2.2 Canada Biodefense Market by Devices
9.1.5.3 Mexico Biodefense Market
9.1.5.3.1 Mexico Biodefense Market by Product
9.1.5.3.2 Mexico Biodefense Market by Devices
9.2. EUROPE
9.2.1 Europe Biodefense Market Overview
9.2.2 Europe Biodefense Market Forecasts and Analysis
9.2.3 Europe Biodefense Market Forecasts and Analysis - By Product
9.2.4 Europe Biodefense Market Forecasts and Analysis - By Devices
9.2.5 Europe Biodefense Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biodefense Market
9.2.5.1.1 Germany Biodefense Market by Product
9.2.5.1.2 Germany Biodefense Market by Devices
9.2.5.2 France Biodefense Market
9.2.5.2.1 France Biodefense Market by Product
9.2.5.2.2 France Biodefense Market by Devices
9.2.5.3 Italy Biodefense Market
9.2.5.3.1 Italy Biodefense Market by Product
9.2.5.3.2 Italy Biodefense Market by Devices
9.2.5.4 Spain Biodefense Market
9.2.5.4.1 Spain Biodefense Market by Product
9.2.5.4.2 Spain Biodefense Market by Devices
9.2.5.5 United Kingdom Biodefense Market
9.2.5.5.1 United Kingdom Biodefense Market by Product
9.2.5.5.2 United Kingdom Biodefense Market by Devices
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biodefense Market Overview
9.3.2 Asia-Pacific Biodefense Market Forecasts and Analysis
9.3.3 Asia-Pacific Biodefense Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Biodefense Market Forecasts and Analysis - By Devices
9.3.5 Asia-Pacific Biodefense Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biodefense Market
9.3.5.1.1 Australia Biodefense Market by Product
9.3.5.1.2 Australia Biodefense Market by Devices
9.3.5.2 China Biodefense Market
9.3.5.2.1 China Biodefense Market by Product
9.3.5.2.2 China Biodefense Market by Devices
9.3.5.3 India Biodefense Market
9.3.5.3.1 India Biodefense Market by Product
9.3.5.3.2 India Biodefense Market by Devices
9.3.5.4 Japan Biodefense Market
9.3.5.4.1 Japan Biodefense Market by Product
9.3.5.4.2 Japan Biodefense Market by Devices
9.3.5.5 South Korea Biodefense Market
9.3.5.5.1 South Korea Biodefense Market by Product
9.3.5.5.2 South Korea Biodefense Market by Devices
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biodefense Market Overview
9.4.2 Middle East and Africa Biodefense Market Forecasts and Analysis
9.4.3 Middle East and Africa Biodefense Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Biodefense Market Forecasts and Analysis - By Devices
9.4.5 Middle East and Africa Biodefense Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biodefense Market
9.4.5.1.1 South Africa Biodefense Market by Product
9.4.5.1.2 South Africa Biodefense Market by Devices
9.4.5.2 Saudi Arabia Biodefense Market
9.4.5.2.1 Saudi Arabia Biodefense Market by Product
9.4.5.2.2 Saudi Arabia Biodefense Market by Devices
9.4.5.3 U.A.E Biodefense Market
9.4.5.3.1 U.A.E Biodefense Market by Product
9.4.5.3.2 U.A.E Biodefense Market by Devices
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biodefense Market Overview
9.5.2 South and Central America Biodefense Market Forecasts and Analysis
9.5.3 South and Central America Biodefense Market Forecasts and Analysis - By Product
9.5.4 South and Central America Biodefense Market Forecasts and Analysis - By Devices
9.5.5 South and Central America Biodefense Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biodefense Market
9.5.5.1.1 Brazil Biodefense Market by Product
9.5.5.1.2 Brazil Biodefense Market by Devices
9.5.5.2 Argentina Biodefense Market
9.5.5.2.1 Argentina Biodefense Market by Product
9.5.5.2.2 Argentina Biodefense Market by Devices

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. BIODEFENSE MARKET, KEY COMPANY PROFILES

11.1. ALNYLAM PHARMACEUTICALS, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAVARIAN NORDIC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ACHAOGEN, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENERAL DYNAMICS INFORMATION TECHNOLOGY, INC.(DYNPORT VACCINE COMPANY LLC)
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ICHOR MEDICAL SYSTEMS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CLEVELAND BIO LABS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. EMERGENT BIOSOLUTIONS INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. DYNAVAX TECHNOLOGIES CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. EMERGENT BIOSOLUTIONS INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ELUSYS THERAPEUTICS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Alnylam Pharmaceuticals, Inc.
2. Bavarian Nordic
3. Achaogen, Inc
4. General Dynamics Information Technology, Inc. (Dynport Vaccine Company LLC)
5. Ichor Medical Systems.
6. Cleveland Bio Labs
7. Emergent Biosolutions Inc.
8. Dynavax Technologies Corporation
9. Xoma Corporation
10. Elusys Therapeutics, Inc.

 

Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book